Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CLNN
Stock Latest News
Company Announcements
Clene Secures Third-Year NIH Subaward for ALS Program
18d ago
8K
CLNN
Premium
The Fly
Clene reports FY25 EPS ($2.65), consensus ($2.35)
23d ago
CLNN
Premium
Company Announcements
Clene outlines 2026 regulatory milestones and ALS strategy
1M ago
8K
CLNN
Premium
The Fly
Clene issues letter to shareholders on CNM-Au8 2026 catalysts
1M ago
CLNN
Premium
Weekend Updates
Madrigal, Clene, Cencora, Sequans, Amicus: Insider Moves Exposed
2M ago
COR
CLNN
Premium
Company Announcements
Clene Announces Multi-Tranche Financing to Extend Cash Runway
3M ago
8K
CLNN
Premium
Company Announcements
Clene Advances CNM-Au8 ALS Program with FDA Meeting
3M ago
8K
CLNN
Premium
The Fly
Clene announces additional CNM-Au8 biomarker data for potential NDA filing
3M ago
CLNN
Premium
The Fly
Clene announces over $28M registered direct offering
3M ago
CLNN
Premium
The Fly
Clene price target raised to $30 from $20 at Maxim
4M ago
CLNN
Premium
Ratings
Clene’s CNM-Au8 Shows Promise in ALS Treatment, Projecting Significant Stock Upside
4M ago
CLNN
Premium
Company Announcements
Clene Updates on CNM-Au8® ALS Program
4M ago
8K
CLNN
Premium
Company Announcements
Clene Announces Positive Biomarker Results for CNM-Au8
4M ago
8K
CLNN
Premium
The Fly
Clene announces significant reductions in NfL, GFAP when treated with CNM-Au8
4M ago
CLNN
Premium
Ratings
Clene Inc.: Promising Future with CNM-Au8 Advancements and Strategic Financial Management
5M ago
CLNN
Premium
Company Announcements
Clene Inc. Reports Continued Financial Losses in Q3 2025
5M ago
CLNN
Premium
The Fly
Clene reports Q3 EPS (85c), consensus (56c)
5M ago
CLNN
Premium
The Fly
Clene sees cash runway into 2Q26
5M ago
CLNN
Premium
Ratings
Buy Rating for Clene’s CNM-Au8 Driven by Promising ALS Treatment Potential and Market Interest
5M ago
CLNN
Premium
Pre-Earnings
Is CLNN a Buy, Before Earnings?
5M ago
CLNN
Premium
Ratings
Clene’s CNM-Au8: A Promising Candidate in ALS Treatment with Buy Rating from Justin Walsh
5M ago
CLNN
Premium
Ratings
Clene’s CNM-Au8: A Promising Game-Changer in ALS Treatment with Buy Rating from Justin Walsh
5M ago
CLNN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
